Apellis Pharmaceuticals Inc (APLS)
27.98
+0.72
(+2.64%)
USD |
NASDAQ |
Nov 01, 16:00
27.97
-0.01
(-0.04%)
After-Hours: 20:00
Apellis Pharmaceuticals Market Cap: 3.407B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 3.407B |
| October 31, 2024 | 3.319B |
| October 30, 2024 | 3.374B |
| October 29, 2024 | 3.338B |
| October 28, 2024 | 3.329B |
| October 25, 2024 | 3.249B |
| October 24, 2024 | 3.358B |
| October 23, 2024 | 3.285B |
| October 22, 2024 | 3.361B |
| October 21, 2024 | 3.273B |
| October 18, 2024 | 3.409B |
| October 17, 2024 | 3.400B |
| October 16, 2024 | 3.403B |
| October 15, 2024 | 3.403B |
| October 14, 2024 | 3.334B |
| October 11, 2024 | 3.305B |
| October 10, 2024 | 3.248B |
| October 09, 2024 | 3.276B |
| October 08, 2024 | 3.336B |
| October 07, 2024 | 3.342B |
| October 04, 2024 | 3.350B |
| October 03, 2024 | 3.417B |
| October 02, 2024 | 3.468B |
| October 01, 2024 | 3.378B |
| September 30, 2024 | 3.512B |
| Date | Value |
|---|---|
| September 27, 2024 | 3.588B |
| September 26, 2024 | 3.635B |
| September 25, 2024 | 3.725B |
| September 24, 2024 | 3.744B |
| September 23, 2024 | 3.984B |
| September 20, 2024 | 3.959B |
| September 19, 2024 | 4.472B |
| September 18, 2024 | 4.339B |
| September 17, 2024 | 4.326B |
| September 16, 2024 | 4.421B |
| September 13, 2024 | 4.581B |
| September 12, 2024 | 4.479B |
| September 11, 2024 | 4.671B |
| September 10, 2024 | 4.771B |
| September 09, 2024 | 4.863B |
| September 06, 2024 | 4.999B |
| September 05, 2024 | 4.784B |
| September 04, 2024 | 4.600B |
| September 03, 2024 | 4.725B |
| August 30, 2024 | 4.737B |
| August 29, 2024 | 4.715B |
| August 28, 2024 | 4.649B |
| August 27, 2024 | 4.822B |
| August 26, 2024 | 4.851B |
| August 23, 2024 | 4.884B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.349B
Minimum
Mar 17 2020
10.87B
Maximum
Jun 13 2023
4.795B
Average
4.605B
Median
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.69B |
| Ionis Pharmaceuticals Inc | 6.113B |
| EyePoint Pharmaceuticals Inc | 645.43M |
| Cassava Sciences Inc | 1.257B |
| Macrogenics Inc | 242.73M |
Market Cap Related Metrics
| PS Ratio | 5.433 |
| Price to Book Value | 12.89 |
| Price | 27.98 |
| Earnings Yield | -9.79% |